An Experimental Treatment With Pembrolizumab in Treating Patients With Advanced Bladder Cancer
This study will use MK-3475 to stimulate your immune system to treat muscle-invasive bladder cancer.
Localized Renal Pelvis and Ureter Urothelial Carcinoma Locally Advanced Bladder Urothelial Carcinoma Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma Locally Advanced Ureter Urothelial Carcinoma Locally Advanced Urothelial Carcinoma Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 Stage II Renal Pelvis and Ureter Cancer AJCC v7 Stage II Ureter Cancer AJCC v7 Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage III Renal Pelvis and Ureter Cancer AJCC v7 Stage III Ureter Cancer AJCC v7 Carcinoma Carcinoma, Transitional Cell Ureteral Neoplasms Kidney Neoplasms Pembrolizumab Clinical Observation Laboratory Biomarker Analysis Pharmacological Study Quality-of-Life Assessment
Lead Scientists at UC Cancer
- James M. Randall (ucsd)
Dr. Randall has recently joined the division, and is building a clinical research program focused on urologic cancer. He is also interested in interventions that may identify and help patients with forms of cancer-related distress, including depression and suicidal ideation.
- Mamta Parikh (ucdavis)
Assistant Professor, Hematology and Oncology. Authored (or co-authored) 10 research publications.
- accepting new patients
- Start Date
- Completion Date
- National Cancer Institute (NCI)
- Phase 3
- Study Type
- Last Updated